---
title: "Report: Private equity group prepares to sell Ensemble Health for up to $12 billion"
description: "Warburg Pincus is planning to sell Ensemble Health Partners for up to $12 billion, and Berkshire Partners is also considering selling the company. The majority shareholders of Ensemble Health are hiri"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/240623170.md"
published_at: "2025-05-16T16:02:31.000Z"
---

# Report: Private equity group prepares to sell Ensemble Health for up to $12 billion

> Warburg Pincus is planning to sell Ensemble Health Partners for up to $12 billion, and Berkshire Partners is also considering selling the company. The majority shareholders of Ensemble Health are hiring advisors to guide the sale, which may involve selling the entire business or a partial stake. Warburg Pincus declined to comment, and other parties involved have not yet responded

According to informed sources, Warburg Pincus is trying to sell the American software group Ensemble Health Partners. Berkshire Partners is also considering selling Ensemble Health. Ensemble Health is expected to achieve a valuation of up to $12 billion (including debt). The majority shareholders of Ensemble are hiring advisors to guide a potential sale, which could lead to a private equity group selling the entire business of Ensemble Health Partners or a partial stake. Warburg Pincus declined to comment, and Berkshire Partners and Ensemble's business partner Bon Secours have not yet responded to requests for comment. (Financial Times)

### Related Stocks

- [BRK.A.US - Berkshire Hathaway](https://longbridge.com/en/quote/BRK.A.US.md)
- [BRK.B.US - Berkshire Hathaway B](https://longbridge.com/en/quote/BRK.B.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Warren Buffett once called these stocks' dividend growth "as certain as birthdays." Here's how they're doing. | Buffett pointed to these two stocks as examples of the key to Berkshire Hathaway's success. | [Link](https://longbridge.com/en/news/273837487.md) |
| Buffett’s $9.7B OxyChem acquisition — why investing experts say it’s genius | Lean how Berkshire Hathaway’s $9.7B OxyChem acquisition boosts cash flow, strengthens Occidental and reflects Warren Buf | [Link](https://longbridge.com/en/news/272899341.md) |
| The Secret Of Warren Buffett’s Storied Success | This week, insights from finance experts suggest that the end of the current secular bull market may be near, as indicat | [Link](https://longbridge.com/en/news/271437747.md) |
| Warren Buffett gifts us 5 secrets for investing success as he hands off Berkshire Hathaway's reins | Warren Buffett, as he steps down as CEO of Berkshire Hathaway, emphasizes the importance of a disciplined investing proc | [Link](https://longbridge.com/en/news/271280487.md) |
| Kraft Heinz shares hit six-year low on Berkshire's potential stake sale | Kraft Heinz shares fell nearly 7% to a six-year low after the company revealed Berkshire Hathaway may sell its 27.5% sta | [Link](https://longbridge.com/en/news/273262453.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.